Company intelligence / Profile preview

CD8 Technology

Warren, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

CD8 Technology provides turnkey R&D and GMP cell therapy facilities; recent agreements with Tevogen Bio enable rapid infrastructure deployment for production of off-the-shelf, genetically unmodified CD8+ T cell therapeutics for cancer, infectious disease, and neurological indications

Industry: Contract Manufacturing Organization

Partnerships

Tevogen Bio (major partnership for cell therapy facility development)

Beyond the preview

Go deeper on CD8 Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD8 Technology.

Explore the full profile